2026 NPPES data Hematology & Oncology Physician NPI 1346762515 MD
Verify on CMS →

Ayesha Hassan, MD

Hematology & Oncology Physician in Cranston, Rhode Island.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
332
Medicare Part D claims · 78 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
70%
generic claims · 30% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$245.37
10 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Ayesha Hassan, MD filed 332 Medicare Part D claims in 2024 as a Hematology & Oncology Physician in Cranston, Rhode Island, prescribing 70% generic.

332
Part D claims, 2024
70%
generic prescribing
Likely
board-certified (heuristic)
≥56th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Ayesha Hassan, MD

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1346762515), first enumerated 07/10/2017.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 332 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $245.37 in reported industry payments (10 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1346762515 · Hematology & Oncology Physician

NPI-10 · ENUM-RECENT · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1346762515
  • ENUM-RECENT 2017
  • TAX-MID 12K Hematology &
  • RX-LIGHT 332
  • BOOK-THIN 65 in Rhode Island
  • PHOTO-ENUM Lubina Arjyal · 2017

Ayesha Hassan, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

332 ≥ 56th percentile 56% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). This entry sits in this band. 400–600: 95,866 prescribers (7%). Above this entry. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Ayesha Hassan, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Ayesha Hassan, MD?

Quality data not reported

NPI registry status

Active

Issued 07/10/2017

NPI 1346762515

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,530 US NPIs in this specialty

Medicare Part D claims

332 62% vs specialty avg

2024 prescription claims

Specialty avg: 885

Specialty distribution in Rhode Island

How Hematology & Oncology Physician compares to other specialties among Rhode Island providers

Rhode Island providers
Clinical Social Worker8.9%Mental Health Counselor5.3%Physical Therapist4.7%Student in an Organized Heal…4.6%Internal Medicine Physician4.2%Pharmacist4.1%Hematology & Oncology Physic…0.3%
Largest specialties in Rhode Island (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

1220 PONTIAC AVE STE 101
Cranston, RI 02920

Provider Details

NPI 1346762515
Specialty Hematology & Oncology Physician
Credentials MD
Gender Female
NPI Issued 07/10/2017

Hospital and facility affiliations

Facilities where Ayesha Hassan, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Affinity Physicians LLC.
Warwick, RI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ayesha Hassan, MD. Source: openpaymentsdata.cms.gov.

Total received

$245

Largest payer

Janssen Pharmaceuticals, Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

Ayesha Hassan, MD - brand share 30.0%
Hematology & Oncology Physician average

30% brand-name claims vs 70% generic, on 332 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

332
Total Claims
$692K
Total Drug Cost
78
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
409.333
Total Day Supply
9,839
Brand vs Generic
30% brand / 70% generic
Brand Drug Cost
$648K
Generic Drug Cost
$44K
Opioid Claims
46 (13.9% rate)

Patient Demographics

Average Patient Age
73.2 years
Avg HCC Risk Score
1.85
Gender Split
54% female / 46% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Ayesha Hassan, MD prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Eliquis
Apixaban
30
Oxycodone Hcl
23
Prochlorperazine Maleate
17
Hydroxyurea
16
Ondansetron Hcl
15
Brukinsa
Zanubrutinib
14
Creon
Lipase/Protease/Amylase
14
Dexamethasone
14
Naloxone Hcl
12
Tagrisso
Osimertinib Mesylate
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Ayesha Hassan, MD fits within the Hematology & Oncology Physician landscape nationally.

11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider

Ayesha Hassan, MD's 332 claims are below the specialty average of 885.

Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Hassan, both outside Rhode Island so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2017)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Hematology & Oncology Physician Providers in Rhode Island

Other clinicians with the same primary specialty enrolled in Rhode Island, drawn from the same CMS NPPES roster as Hassan.

One of 65 Hematology & Oncology Physician providers enrolled in Rhode Island, 5 are shown here.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Ayesha Hassan, MD's specialty?
Ayesha Hassan, MD specializes in Hematology & Oncology Physician and practices in Cranston, Rhode Island. Credentials: MD.
How much does Ayesha Hassan, MD prescribe under Medicare Part D?
In 2024, Ayesha Hassan, MD wrote 332 Medicare Part D claims totaling $692K in drug costs for 78 beneficiaries.
Where is Ayesha Hassan, MD located?
Ayesha Hassan, MD is located at 1220 PONTIAC AVE STE 101, Cranston, RI, 02920. Phone: (401) 943-4660.
What is Ayesha Hassan, MD's NPI number?
Ayesha Hassan, MD's National Provider Identifier (NPI) is 1346762515, issued on 07/10/2017.
Does Ayesha Hassan, MD prescribe more brand-name or generic drugs?
Ayesha Hassan, MD's prescribing is 30% brand-name and 70% generic drugs by claim count, with $648K in brand drug costs.
Does Ayesha Hassan, MD prescribe opioids?
Yes, Ayesha Hassan, MD had 46 opioid claims in 2024 with an opioid prescribing rate of 13.9%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Ayesha Hassan, MD prescribe most often?
Based on 2024 Medicare Part D data, Ayesha Hassan, MD's most frequently prescribed drugs include Eliquis, Oxycodone Hcl, Prochlorperazine Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ayesha Hassan, MD accept Medicare?
Ayesha Hassan, MD appears in CMS Medicare data with 332 Part D claims and 78 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ayesha Hassan, MD's credentials?
Ayesha Hassan, MD's NPI is 1346762515 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.